APMD vs NGNE: stock comparison and AI forecast
Apnimed, Inc. (APMD) and Neurogene Inc. (NGNE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
APMD Apnimed, Inc.
- Price
- $14.16 -50.8% · 6M
- Market Cap
- $589M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NGNE Neurogene Inc.
- Market Cap
- $513M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- APMD is 1.1 times larger than NGNE by market capitalization ($589M against $513M).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | APMD | NGNE |
|---|---|---|
| Market Cap | $589M | $513M |
| P/B Ratio | – | 2.36x |
| EPS | – | $-5.03 |
| Book Value/Share | – | $10.85 |
| FCF/Share | – | $-4.38 |
Profitability & Margins
| Metric | APMD | NGNE |
|---|---|---|
| ROE | – | -51.2% |
| ROA | – | -45.5% |
| ROIC | – | -54.5% |
Financial Health
| Metric | APMD | NGNE |
|---|---|---|
| Current Ratio | 5.19x | 10.64x |
| D/E Ratio | – | 0.13x |
| Financial Leverage | – | 1.13x |
| Interest Coverage | – | 6882.5x |
| Working Capital | $149M | $207M |
Cash Flow
| Metric | APMD | NGNE |
|---|---|---|
| Operating Cash Flow | – | -$87M |
| Free Cash Flow | – | -$88M |
| Capital Spending | – | -$890K |
Income Statement
| Metric | APMD | NGNE |
|---|---|---|
| Operating Income | – | -$121M |
| Net Income | – | -$111M |
| R&D Expense | – | $88M |
Dividend & Shareholder Information
| Metric | APMD | NGNE |
|---|---|---|
| Shares Outstanding | 42M | 20M |
APMD vs NGNE: stock comparison and AI forecast
Which is bigger, APMD or NGNE?
APMD is 1.1 times larger than NGNE by market capitalization ($589M against $513M).
Which one does Intratio's AI model rank higher, APMD or NGNE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.